Because post-traumatic cortical demyelination can affect clinical outcomes and may even reflect the risk for neurodegenerative diseases like AD, future studies should further investigate this phenomenon relative to other factors like age, sex, APOE genotype, cognitive function, and other biological factors. This evidence concerns the gene APOE and Alzheimer disease.